Funobactam

Funobactam

File:Funobactam.svg

Chemical structure of Funobactam

Funobactam is a novel antibiotic compound that belongs to the class of beta-lactamase inhibitors. It is primarily used in combination with other antibiotics to enhance their efficacy against resistant bacterial strains. Funobactam is particularly effective against Gram-negative bacteria, which are known for their robust resistance mechanisms.

Mechanism of Action

Funobactam works by inhibiting the activity of beta-lactamase enzymes produced by certain bacteria. These enzymes are responsible for breaking down beta-lactam antibiotics, rendering them ineffective. By inhibiting these enzymes, Funobactam allows beta-lactam antibiotics to retain their antibacterial activity, thus overcoming bacterial resistance.

Clinical Applications

Funobactam is used in combination with beta-lactam antibiotics such as penicillins and cephalosporins. This combination is particularly useful in treating infections caused by multi-drug resistant organisms, including those producing extended-spectrum beta-lactamases (ESBLs) and carbapenem-resistant Enterobacteriaceae (CRE).

Pharmacokinetics

The pharmacokinetic profile of Funobactam is characterized by its ability to achieve high concentrations in the bloodstream, which is essential for its effectiveness as a beta-lactamase inhibitor. It is typically administered intravenously, and its dosage is adjusted based on the severity of the infection and the patient's renal function.

Safety and Side Effects

Funobactam is generally well-tolerated, with a safety profile similar to other beta-lactamase inhibitors. Common side effects include nausea, diarrhea, and allergic reactions. Serious adverse effects are rare but can include anaphylaxis and seizures, particularly in patients with renal impairment.

Development and Research

Research on Funobactam is ongoing, with studies focusing on its efficacy against emerging resistant bacterial strains. It is part of a broader effort to develop new antibiotics and adjuvants to combat antibiotic resistance, a growing public health concern.

Related Pages

• Antibiotic resistance
• Beta-lactam antibiotics
• Gram-negative bacteria
• Extended-spectrum beta-lactamase